Pall Corporation PLL reported 2Q:F11 EPS from operations of $0.68 versus $0.42 in the year-ago period and the Street consensus estimate of $0.57. The difference between reported results and JPM's estimate was due to higher than expected Biopharmaceutical and Energy & Water volumes versus its expectation. Industrial operating profits of $83.7M were above J.P Morgan's projection of $73.4M and Life Sciences operating profits of $47.9M were also above the $36.3M forecast. Overhead was consistent with expectations and higher sales led to higher gross profits.
J.P Morgan expects the shares to trade up for the day. Pall raised its F2011 EPS guidance to a range of $2.80-2.90 versus $2.48-2.63 previously and the current Bloomberg consensus of $2.62. Pall's guidance includes a F2011 currency benefit of $0.09/share versus its previous assumption of neutral currency effects.
JPM has a Neutral rating on PLL
PLL closed Thursday at $53.69
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.